These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1263520

  • 1. Tritiated thymidine labeling index of benign and malignant human breast epithelium.
    Meyer JS, Bauer WC.
    J Surg Oncol; 1976; 8(2):165-81. PubMed ID: 1263520
    [Abstract] [Full Text] [Related]

  • 2. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.
    Meyer JS.
    Hum Pathol; 1977 Jan; 8(1):67-81. PubMed ID: 844855
    [Abstract] [Full Text] [Related]

  • 3. Thymidine labeling index in breast tumors.
    Lee HD, Soh EY, Chi HS, Kim BR, Lee KS, Song KS, Jung HJ.
    Jpn J Surg; 1990 Mar; 20(2):180-5. PubMed ID: 1692890
    [Abstract] [Full Text] [Related]

  • 4. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.
    Meyer JS, Prey MU, Babcock DS, McDivitt RW.
    Lab Invest; 1986 Jan; 54(1):41-51. PubMed ID: 3941541
    [Abstract] [Full Text] [Related]

  • 5. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.
    Going JJ, Anderson TJ, Battersby S, MacIntyre CC.
    Am J Pathol; 1988 Jan; 130(1):193-204. PubMed ID: 3337211
    [Abstract] [Full Text] [Related]

  • 6. Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.
    Meyer JS, Province M.
    Breast Cancer Res Treat; 1988 Oct; 12(2):191-204. PubMed ID: 3242648
    [Abstract] [Full Text] [Related]

  • 7. Prediction of early course of breast carcinoma by thymidine labeling.
    Meyer JS, Friedman E, McCrate MM, Bauer WC.
    Cancer; 1983 May 15; 51(10):1879-86. PubMed ID: 6831353
    [Abstract] [Full Text] [Related]

  • 8. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.
    Meyer JS, Hixon B.
    Cancer Res; 1979 Oct 15; 39(10):4042-7. PubMed ID: 476641
    [Abstract] [Full Text] [Related]

  • 9. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
    Kamel OW, Franklin WA, Ringus JC, Meyer JS.
    Am J Pathol; 1989 Jan 15; 134(1):107-13. PubMed ID: 2536520
    [Abstract] [Full Text] [Related]

  • 10. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S, Croton R, Leinster SJ, McDicken I, Nicholson RI, Cooke TG, George WD.
    Eur J Surg Oncol; 1986 Mar 15; 12(1):53-7. PubMed ID: 3956755
    [Abstract] [Full Text] [Related]

  • 11. Reliability and stability of the thymidine labeling index of breast carcinoma.
    Meyer JS, McDivitt RW.
    Lab Invest; 1986 Feb 15; 54(2):160-4. PubMed ID: 3945050
    [Abstract] [Full Text] [Related]

  • 12. Thymidine labeling index of human breast carcinoma. Enhancement of in vitro labeling by 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Meyer JS, Facher R.
    Cancer; 1977 Jun 15; 39(6):2524-32. PubMed ID: 141321
    [Abstract] [Full Text] [Related]

  • 13. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
    Meyer JS.
    NCI Monogr; 1986 Jun 15; (1):25-8. PubMed ID: 3774013
    [Abstract] [Full Text] [Related]

  • 14. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.
    Meyer JS, Coplin MD.
    Am J Clin Pathol; 1988 May 15; 89(5):586-95. PubMed ID: 3358366
    [Abstract] [Full Text] [Related]

  • 15. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N.
    Indian J Pathol Microbiol; 2009 May 15; 52(4):477-81. PubMed ID: 19805950
    [Abstract] [Full Text] [Related]

  • 16. Labeling index in squamous cell carcinoma of the larynx.
    Balzi M, Ninu BM, Becciolini A, Scubla E, Boanini P, Gallina E, Gallo O, Fini-Storchi O, Bondi R.
    Head Neck; 1991 May 15; 13(4):344-8. PubMed ID: 1869437
    [Abstract] [Full Text] [Related]

  • 17. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.
    Meyer JS, Rao BR, Stevens SC, White WL.
    Cancer; 1977 Nov 15; 40(5):2290-8. PubMed ID: 922670
    [Abstract] [Full Text] [Related]

  • 18. Cell kinetic analysis of human breast carcinomas.
    Meyer JS.
    Monogr Pathol; 1984 Nov 15; (25):45-58. PubMed ID: 6377051
    [Abstract] [Full Text] [Related]

  • 19. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN, Findlay PA, McDonald HD, Lippman ME, Reichert CM, d'Angelo T, Gorrell CR, Gerber NL, Lichter AS, Rosenberg SA.
    J Clin Oncol; 1986 May 15; 4(5):655-62. PubMed ID: 3701387
    [Abstract] [Full Text] [Related]

  • 20. A method of labeling tissues with tritiated thymidine in vitro and its use in comparing rates of cell proliferation in duct epithelium, fibroadenoma, and carcinoma of human breast.
    JOHNSON HA, BOND VP.
    Cancer; 1961 May 15; 14():639-43. PubMed ID: 13790278
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.